Cerulean completes IPO

Cerulean Pharma Inc. (NASDAQ: CERU), Cambridge, Mass. Business: Drug delivery, Cancer Date completed: 4/10/14 Type: IPO Raised: $59.5 million Shares: 8.5 million Price: $7 Shares after offering: 19 mi...